Early access
Sign in
Taking peoplePhase 1

Tests TU7710 safety in people with haemophilia A or B

Tests TU7710 in adults with haemophilia A or B for safety.

Key facts

Who runs it
Tiumbio Co. Ltd.
Where
Florence, ItalySee the siteAlso in 3 other countries, 5 sites
Registry title
A Phase Ib Safety, Pharmacokinetics and Pharmacodynamics Study of TU7710 in Patients with Haemophilia A or B
Status
Recruiting
Phase
Phase 1
People taking part
21 people, planned
Started
10 Dec 2024
Expected to end
31 Dec 2026
Type of study
Interventional
Record updated
18 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adult men with haemophilia A or B.

Age
18 years or older
Sex
Men only

Where in Italy

Also in 3 other countries, 5 sites

  • Careggi University HospitalFlorence, ItalyNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Tests TU7710 safety in people with haemophilia A or BGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
18 September 2026